6YTD
CLK1 V324A mutant bound with benzothiazole Tg003 (Cpd 2)
Summary for 6YTD
| Entry DOI | 10.2210/pdb6ytd/pdb |
| Descriptor | Dual specificity protein kinase CLK1, (1~{Z})-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one (3 entities in total) |
| Functional Keywords | inhibitor, complex, clk1, structural genomics, structural genomics consortium, sgc, transferase |
| Biological source | Homo sapiens (Human) |
| Total number of polymer chains | 1 |
| Total formula weight | 39802.79 |
| Authors | Schroeder, M.,Chaikuad, A.,Knapp, S.,Structural Genomics Consortium (SGC) (deposition date: 2020-04-24, release date: 2020-07-15, Last modification date: 2024-01-24) |
| Primary citation | Schroder, M.,Bullock, A.N.,Fedorov, O.,Bracher, F.,Chaikuad, A.,Knapp, S. DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity. J.Med.Chem., 63:10224-10234, 2020 Cited by PubMed: 32787076DOI: 10.1021/acs.jmedchem.0c00898 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report
